Edgewood Management Portfolio holdings
AUM
$31.5B
This Quarter Return
-14.08%
1 Year Return
+19.46%
3 Year Return
+128.01%
5 Year Return
+144.65%
10 Year Return
+626.11%
AUM
$49.9B
AUM Growth
-$11.1B
(-18%)
Cap. Flow
-$1.81B
Cap. Flow
% of AUM
-3.63%
Top 10 Holdings %
Top 10 Hldgs %
55.67%
Holding
90
New
5
Increased
11
Reduced
23
Closed
6
Top Buys
| 1 |
ASML
ASML
|
$1.58B |
| 2 |
ServiceNow
NOW
|
$1.52B |
| 3 |
Intuitive Surgical
ISRG
|
$454M |
| 4 |
NVIDIA
NVDA
|
$263M |
| 5 |
Snap
SNAP
|
$237M |
Top Sells
| 1 |
PayPal
PYPL
|
$3.12B |
| 2 |
Meta Platforms (Facebook)
META
|
$1.86B |
| 3 |
Equinix
EQIX
|
$894M |
| 4 |
CME Group
CME
|
$267M |
| 5 |
SPDR S&P 500 ETF Trust
SPY
|
$28.2M |
Sector Composition
| 1 | Technology | 27.74% |
| 2 | Healthcare | 20.22% |
| 3 | Financials | 16.54% |
| 4 | Communication Services | 13.5% |
| 5 | Consumer Discretionary | 11.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
BioMarin Pharmaceuticals
BMRN
$11.3B
| $1.16M | ﹤0.01% |
15,000
| – | – |
|
52
Prothena Corp
PRTA
$452M
| $914K | ﹤0.01% |
25,000
| – | – |
|
53
Royalty Pharma
RPRX
$15.8B
| $896K | ﹤0.01% |
23,000
| – | – |
|
54
Vodafone
VOD
$28.2B
| $879K | ﹤0.01% |
52,886
-3,811
| -7% | -$63.3K |
|
55
Arrowhead Research
ARWR
$3.84B
| $874K | ﹤0.01% |
19,000
| – | – |
|
56
Exxon Mobil
XOM
$477B
| $815K | ﹤0.01% |
9,865
-619
| -6% | -$51.1K |
|
57
Zoetis
ZTS
$67.6B
| $764K | ﹤0.01% |
4,053
+473
| +13% | +$89.2K |
|
|
SPLK
58
DELISTED
Splunk Inc
SPLK
| $743K | ﹤0.01% |
5,000
| – | – |
|
59
Ecolab
ECL
$77.5B
| $733K | ﹤0.01% |
4,149
| – | – |
|
60
Freeport-McMoran
FCX
$66.3B
| $712K | ﹤0.01% |
14,319
| – | – |
|
61
United Rentals
URI
$60.8B
| $710K | ﹤0.01% |
2,000
| – | – |
|
62
AT&T
T
$208B
| $697K | ﹤0.01% |
39,058
| – | – |
|
63
Charles Schwab
SCHW
$175B
| $671K | ﹤0.01% |
7,960
| – | – |
|
64
Tesla
TSLA
$1.08T
| $655K | ﹤0.01% |
1,824
-381
| -17% | -$137K |
|
65
Merck
MRK
$210B
| $641K | ﹤0.01% |
7,818
| – | – |
|
66
Duke Energy
DUK
$94.5B
| $611K | ﹤0.01% |
5,468
| – | – |
|
67
Agios Pharmaceuticals
AGIO
$2.36B
| $582K | ﹤0.01% |
+20,000
| New | +$582K |
|
68
Seer Inc
SEER
$114M
| $533K | ﹤0.01% |
35,000
+10,000
| +40% | +$152K |
|
69
Seres Therapeutics
MCRB
$162M
| $498K | ﹤0.01% |
3,500
| – | – |
|
70
Armata Pharmaceuticals
ARMP
$109M
| $489K | ﹤0.01% |
100,000
| – | – |
|
71
Verizon
VZ
$184B
| $439K | ﹤0.01% |
8,616
| – | – |
|
72
Stryker
SYK
$149B
| $428K | ﹤0.01% |
1,600
| – | – |
|
73
BlackRock New York Municipal Income Trust
BNY
$231M
| $426K | ﹤0.01% |
35,000
| – | – |
|
74
Annaly Capital Management
NLY
$13.8B
| $366K | ﹤0.01% |
13,000
| – | – |
|
|
ETG
75
Eaton Vance Tax-Advantaged Global Dividend Income Fund
ETG
$1.59B
| $350K | ﹤0.01% |
17,000
| – | – |
|